Amgen’s Repatha proves effective in major cardiovascular outcomes study

Amgen Inc. has achieved a significant milestone with its cholesterol-lowering injection, Repatha (evolocumab), demonstrating a 20% reduction in heart attack and stroke risks among patients ... Read More